ORTEXORTEX News
Tracking TOL? Get live short interest, options flow, and signals on ORTEX.Sign up free →
TO
Trader NoteTOL

Toll Brothers: Shorts Retreat as Analysts Initiate Coverage

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 3 min readdata as of 21 Oct 2026, 19:02

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Toll Brothers enters the final stretch of October with a distinctive split in its data: short sellers have been cutting positions at pace even as options traders maintain an unusually defensive stance, and the Street's fresh wave of analyst initiations lands with the stock still trading well below consensus targets.

The short position dropped nearly 20% over the past week, falling from roughly 4.86 million shares to 3.93 million. That puts short interest at 4.1% of the free float, down from a recent peak above 4.8 million shares on October 12. The retreat has been fast and consistent, with shorts trimming every session since mid-month. Borrowing costs confirm the same direction: the cost to borrow has fallen 29% over the week to just 0.30%, its lowest level since early October, and is down 37% over the past month. Availability is essentially unconstrained, with more than 91 million shares still available to lend against roughly 3.9 million shorted, a ratio that gives would-be shorts no friction whatsoever in opening new positions. The lending market is, in short, very relaxed.

Options positioning tells a different story. The put/call ratio is running at 1.54, above its 20-day average of 1.50, and close to the 52-week high of 1.60 reached at the end of September. That ratio has been elevated for weeks, pointing to persistent demand for downside protection even as the short book has lightened. The z-score of 0.87 keeps the reading in cautious rather than extreme territory, but the gap between a retreating short position and a still-heavy put ratio is the week's clearest tension.

The analyst picture has turned notably busier. Four firms have published new or revised views on TOL in the past two weeks alone. Citigroup maintained its Buy rating but cut its target from $179 to $168, while RBC Capital trimmed its Outperform target from $158 to $148. Both reductions reflect a more cautious view on near-term delivery volumes and margin pressure. StoneX initiated with a Buy and a $165 target on October 16. Melius Research also initiated at Buy with a $179 target earlier in the month, the highest current target on the Street. Morgan Stanley's October initiation at Overweight with a $159 target adds another constructive voice. The one outlier is Barclays, which maintained Underweight and nudged its target down from $122 to $118, the sole bear among recent movers. The consensus sits firmly at Buy, with a mean target of $168.83 against a current price of $135.50, implying roughly 25% upside on the Street's numbers. The valuation remains undemanding, with the stock trading at about 10x earnings and 7.8x EV/EBITDA.

The bull case rests on Toll's positioning at the luxury end of the market, where buyers with greater equity and cash flexibility are less sensitive to mortgage rate fluctuations. Revenue from home sales ran at $2.65 billion in the most recent quarter, with a 25.6% adjusted gross margin and a $700 million buyback authorisation. The bear case points to a sequential deterioration: deliveries fell 10% and home sale revenue dropped 8% year over year in the July quarter, with gross margin slipping to 23.9% as incentives and higher administrative costs bit into profitability. Those pressures are the source of the wave of modest target cuts even from analysts who remain constructive on the name.

On the ownership side, BlackRock raised its stake to 10.1% in its most recent filing, and T. Rowe Price added more than 1.5 million shares to bring its holding to just under 2.2%. Insider activity has been limited to a single small director sale of 800 shares in late September, with no open-market buying in the past 90 days. The most significant insider transaction in recent months was Executive Chairman Douglas Yearley's exercise of options and simultaneous sale of nearly 78,000 shares in June, a routine exercise-and-sell rather than a discretionary bet.

The next earnings print is scheduled for December 8, giving the market about seven weeks to decide whether the modest contract growth reported for July holds into autumn, or whether the rate and affordability pressures flagged by the bears begin to weigh more visibly on bookings and margin guidance.

Stocks in this article

See the live data behind this article on ORTEX.

Open TOL on ORTEX →

How this article was generated

Generated
21 Oct 2026, 19:10
Data as of
21 Oct 2026, 19:02
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.